Authors : C. Ezzouitina; C. Fatima Zahra; R. Laraichi; I. Lahlali; M. Farina; A. Lachgar; K. Nouni; H. El Kacemi; T. Kebdani; K. Hassouni

Volume/Issue : Volume 10 - 2025, Issue 8 - August

Google Scholar : https://tinyurl.com/yc7th476

Scribd : https://tinyurl.com/2vnp2nh3

DOI : https://doi.org/10.38124/ijisrt/25aug545

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract :  Introduction Cervical cancer and its treatments can have a significant impact on various aspects of sexual health, including physical function, emotional well-being, and intimate relationships. Survivors often face changes in body image, sexual function, desire, and intimacy. There is a growing awareness of the importance of sexual health in the quality of life of cervical cancer survivors. This study aims to assess various aspects of sexual function, including desire, vaginal lubrication, orgasm, satisfaction, and pain, as well as their impact on quality of life.  Methods This prospective study included patients who had completed their treatment for gynecological cancer between 6 months and 1 year prior, from January 2022 to January 2024, at the Radiotherapy Department of the National Institute of Oncology in Rabat. Patients completed the following questionnaires: The Female Sexual Function Index (FSFI).  Results The study included 220 patients, with a median age of 47,2 years. After treatment, 62% of women scored below the FSFI cutoff for sexual dysfunction, Factors significantly associated with sexual dysfunction included brachytherapy, age over 50, low socioeconomic status, longer time since treatment, and perceived low partner interest. Women treated with chemoradiotherapy and brachytherapy had significantly lower FSFI scores (19.4 ± 4.8) than those treated without brachytherapy (22.7 ± 3.7, p < 0.01).  Conclusion Sexual dysfunction in cervical cancer survivors is a complex issue requiring early detection and appropriate patient education to improve their quality of life.

Keywords : Cervical Cancer, Sexual Dysfunction, Survivorship.

References :

1. Gavrilova N, Anderson D (2007) Sexual morbidity in very long term survivors of vaginal and cervical cancer: a comparison to national norms. Gynecol Oncol 106:413–418
2. Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D (2004) Early-stage cervical carcinoma, radical Archives of Gynecology and Obstetrics hysterectomy, and sexual function. A longitudinal study. Cancer 100:97–106
3. Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D. Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. International Journal of Radiation Oncology Biology Physics 2003;56:937-949. DOI: 10.1016/S0360-3016(03)00362-6
4. Bergmark K, Avall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G. Vaginal changes and sexuality in women with a history of cervical cancer. New England Journal of Medicine 1999;340:1383-1389. DOI: 10.1056/NEJM199905063401802
5. Kwekkeboom KL, Abbott-Anderson K, Cherwin C, Roiland R, Serlin RC, Ward SE (2012) Pilot randomized controlled trial of a patient-controlled cognitive-behavioral intervention for the pain, fatigue, and sleep disturbance symptom cluster in cancer. J Pain Symptom Manag
6. Pacagnella RC, Vieira EM, Rodrigues OM Jr, Souza C (2008) Adaptac¸a˜o transcultural do female sexual function index. Cad Saude Publica. 24(2):416–426
7. Tarek H. Anis, MD, Samah Aboul Gheit, MD, Hanan S. Saied, MD, Samar A. Al_kherbash, MD, Arabic Translation of Female Sexual Function Index and Validation in an Egyptian Population, The Journal of Sexual Medicine, Volume 8, Issue 12, December 2011, Pages 3370–3378, https://doi.org/10.1111/j.1743-6109.2011.02471.x
8. Baser RE, Li Y, Carter J (2012) Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors. Cancer 118(18):4606–4618
9. Wiegel M, Meston C, Rosen R (2005) The Female Sexual Function Index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 31(1):1–20
10. Andersen BL, Woods XA, Copeland LJ. Sexual self-schema and sexual morbidity among gynecologic cancer survivors. J Consult Clin Psychol. 1997;65:221–9. doi: 10.1037//0022-006x.65.2.221. 
11. Brandenbarg, D., et al. (2018). Sexual health in cancer survivors: A systematic review. Cancer Treatment Reviews, 69, 1-10.
12. Zebrack, B. J., et al. (2015). Sexuality in cancer survivors: A comprehensive review. Supportive Care in Cancer, 23(5), 1381-1391.
13. Lima CS, et al. Sexual function of women surviving cervical cancer. Arch Gynecol Obstet. 2015;292(4):885–891.
14. Carter J, et al. Contemporary quality of life issues affecting gynecologic cancer survivors. Hematol Oncol Clin North Am. 2012;26(1):169–194.
15. Donovan KA, et al. Sexual health in women treated for cervical cancer: characteristics and correlates. Gynecol Oncol. 2007;104(2):428–434.
16. White ID. Assessment and management of sexual difficulties after treatment of cervical and endometrial malignancies. Clin Oncol. 2008;20(6):488–496.
17. Frumovitz M, et al. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol. 2005;23(30):7428–7436.
18. Greimel ER, et al. Quality of life and sexual functioning after cervical cancer treatment: a long-term follow-up study. Psychooncology. 2009;18(5):476–482.
19. Fernandes WC, Kimura M (2010) Qualidade de vida relacionada a` sau´de de mulheres com caˆncer de colo uterino. Rev Lat Am Enfermagem 18(3):360–367
20. Cleary V, Hegarty J. Understanding sexuality in women with gynaecological cancer. Eur J Oncol Nurs. 2011;15(1):38–45.
21. Sexuality of Moroccan Survivors of Cervical Cancer: A Prospective Data Zineb Dahbi 1, Ali Sbai, Loubna Mezouar PMCID: PMC6318393 DOI: 10.31557/APJCP.2018.19.11.3077
22. Huguet PR, et al. Qualité de vie et sexualité de femmes traitées pour cancer du sein. Rev Bras Ginecol Obstet. 2009;31(2):31–37.
23. Golbasi Z, Erenel AS (2012) The quality of sexual life in women with gynaecological cancers. Arch Gynecol Obstet 285(6):1713–1717
24. Fleury HJ, Pantaroto HSC, Abdo CHN (2011) Sexualidade em oncologia. Diagn Tratamento. 16(2):86–90
25. Iavazzo C, Johnson K, Savage H, Gallagher S, Datta M, Winter- Roach BA (2015) Sexuality issues in gynaecological oncology patients: post treatment symptoms and therapeutic options. Arch Gynecol Obstet 291:653–656
26. Herzog TJ, Wright JD (2007) The impact of cervical cancer on quality of life—the components and means for management. Gynecol Oncol 107(3):572–577
27. Stilos K, Doyle C, Daines P (2008) Addressing the sexual health needs of patients with gynecologic cancers. Clin J Oncol Nurs 12(3):457–463
28. Lindau ST, Gavrilova N, Anderson D (2007) Sexual morbidity in very long term survivors of vaginal and cervical cancer: a comparison to national norms. Gynecol Oncol 106(2):413–418
29. Rutledge TL, Heckman SR, Qualls C, Muller CY, Rogers RG (2010) Pelvic floor disorders and sexual function in gynecologic cancer survivors: a cohort study. Am J Obstet Gynecol. 203(5):e1–e7
30. Schover LR. Sexuality and fertility after cancer. Hematol Oncol Clin North Am. 2005;19(3):771-796. doi:10.1016/j.hoc.2005.04.012
31. Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D. Early-stage cervical carcinoma, radical hysterectomy, and sexual function. A longitudinal study. Cancer. 2004;100(1):97-106.